Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 No longer going to waste.

Literature DB >> 27153267

No longer going to waste.

Ken Garber.

Abstract

Mesh：

Substances：

Year: 2016 PMID： 27153267 DOI： 10.1038/nbt.3557

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

12 in total

Review 1. Prospect for pharmacological therapies to treat skeletal muscle dysfunction.

Authors: Matthew N Meriggioli; Ronenn Roubenoff
Journal: Calcif Tissue Int Date: 2014-11-04 Impact factor: 4.333

2. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.

Authors: A C McPherron; A M Lawler; S J Lee
Journal: Nature Date: 1997-05-01 Impact factor: 49.962

3. Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.

Authors: Tommaso Poggioli; Ana Vujic; Peiguo Yang; Claudio Macias-Trevino; Aysu Uygur; Francesco S Loffredo; James R Pancoast; Miook Cho; Jill Goldstein; Rachel M Tandias; Emilia Gonzalez; Ryan G Walker; Thomas B Thompson; Amy J Wagers; Yick W Fong; Richard T Lee
Journal: Circ Res Date: 2015-10-21 Impact factor: 17.367

4. Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

Authors: Se-Jin Lee; Lori A Reed; Monique V Davies; Stefan Girgenrath; Mary E P Goad; Kathy N Tomkinson; Jill F Wright; Christopher Barker; Gregory Ehrmantraut; James Holmstrom; Betty Trowell; Barry Gertz; Man-Shiow Jiang; Suzanne M Sebald; Martin Matzuk; En Li; Li-Fang Liang; Edwin Quattlebaum; Ronald L Stotish; Neil M Wolfman
Journal: Proc Natl Acad Sci U S A Date: 2005-12-05 Impact factor: 11.205

5. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.

Authors: Marc A Egerman; Samuel M Cadena; Jason A Gilbert; Angelika Meyer; Hallie N Nelson; Susanne E Swalley; Carolyn Mallozzi; Carsten Jacobi; Lori L Jennings; Ieuan Clay; Gaëlle Laurent; Shenglin Ma; Sophie Brachat; Estelle Lach-Trifilieff; Tea Shavlakadze; Anne-Ulrike Trendelenburg; Andrew S Brack; David J Glass
Journal: Cell Metab Date: 2015-05-19 Impact factor: 27.287

6. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Authors: James T Dalton; Kester G Barnette; Casey E Bohl; Michael L Hancock; Domingo Rodriguez; Shontelle T Dodson; Ronald A Morton; Mitchell S Steiner
Journal: J Cachexia Sarcopenia Muscle Date: 2011-08-02 Impact factor: 12.910

7. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors.

Authors: Lida Katsimpardi; Nadia K Litterman; Pamela A Schein; Christine M Miller; Francesco S Loffredo; Gregory R Wojtkiewicz; John W Chen; Richard T Lee; Amy J Wagers; Lee L Rubin
Journal: Science Date: 2014-05-05 Impact factor: 47.728

8. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.

Authors: Manisha Sinha; Young C Jang; Juhyun Oh; Danika Khong; Elizabeth Y Wu; Rohan Manohar; Christine Miller; Samuel G Regalado; Francesco S Loffredo; James R Pancoast; Michael F Hirshman; Jessica Lebowitz; Jennifer L Shadrach; Massimiliano Cerletti; Mi-Jeong Kim; Thomas Serwold; Laurie J Goodyear; Bernard Rosner; Richard T Lee; Amy J Wagers
Journal: Science Date: 2014-05-05 Impact factor: 47.728

9. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

Authors: José M Garcia; Ralph V Boccia; Charles D Graham; Ying Yan; Elizabeth Manning Duus; Suzan Allen; John Friend
Journal: Lancet Oncol Date: 2014-12-16 Impact factor: 41.316

10. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors: Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal: Cell Date: 2013-05-09 Impact factor: 41.582

34 in total

Review 1. Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.

Authors: Richard F Dunne; Karen M Mustian; Jose M Garcia; William Dale; Reid Hayward; Breton Roussel; Mary M Buschmann; Bette J Caan; Calvin L Cole; Fergal J Fleming; Joe V Chakkalakal; David C Linehan; Aram F Hezel; Supriya G Mohile
Journal: Curr Opin Support Palliat Care Date: 2017-12 Impact factor: 2.302

2. Myostatin regulates pituitary development and hepatic IGF1.

Authors: Wioletta Czaja; Yukiko K Nakamura; Naisi Li; Jennifer A Eldridge; David M DeAvila; Thomas B Thompson; Buel D Rodgers
Journal: Am J Physiol Endocrinol Metab Date: 2019-03-19 Impact factor: 4.310

3. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents.

Authors: Dongryeol Ryu; Laurent Mouchiroud; Pénélope A Andreux; Elena Katsyuba; Norman Moullan; Amandine A Nicolet-Dit-Félix; Evan G Williams; Pooja Jha; Giuseppe Lo Sasso; Damien Huzard; Patrick Aebischer; Carmen Sandi; Chris Rinsch; Johan Auwerx
Journal: Nat Med Date: 2016-07-11 Impact factor: 53.440

Review 9. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.

Authors: L A Consitt; B C Clark
Journal: J Frailty Aging Date: 2018

10. Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models.

Authors: Megumi Morimoto; Katsuji Aikawa; Takahito Hara; Masuo Yamaoka
Journal: Oncol Lett Date: 2017-10-17 Impact factor: 2.967